
1 / 7Growth Factor & Tissue Signaling Research · Popular Peptides
$62.40$31.20Save 50%
CJC-1295 (no DAC), also referenced as modified GRF (1-29), is a synthetic 30-amino-acid analogue of the first 29 residues of growth hormone-releasing hormone, produced by solid-phase peptide synthesis and studied in vitro and in animal models as a GHRH-receptor agonist. Without the Drug Affinity Complex, it is investigated for short-acting signaling profiles in endocrine and cell-culture research.
Real Peptides supplies this compound as a 10mg lyophilized multi-dose vial. Every lot is assayed by an independent laboratory, and the certificate of analysis for the current lot is published on the lab results page so researchers can review identity and purity before purchase. Orders ship from Florida or California facilities within 24 hours. Sold for laboratory research use only; not for human or veterinary use.
Quantity
$31.20
CJC 1295 (no dac) · 5mg
$31.20$62.40
For Research Use Only. Not for human consumption or therapeutic treatment.
CJC-1295 No DAC is a fast-acting growth-hormone-releasing peptide that sparks natural GH spikes in lab models without lingering in the system. It’s used to study how short bursts of GH drive IGF-1, lean-mass gains, and hormone feedback—perfect for muscle-biology and endocrine research. Each 10 mg vial is tested to ≥99% purity, low-endotoxin certified, and comes with a full Certificate of Analysis.


Growth Factor & Tissue Signaling Research compounds